Vimarsana
Biggest News Aggregation in the World

Page 14 - Ir Team News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ir Team. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ir Team Today - Breaking & Trending Today

Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to the UK Medicines and Healthcare Products Regulatory Agency - Vimarsana News

Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to the UK Medicines and Healthcare Products Regulatory Agency

-- 2nd MAA submission in Europe reflects toripalimab's steady yet speedy progress towards global commercializationSHANGHAI, China, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection - Vimarsana News

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection

Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection

Junshi Biosciences Announces Approval of Supplemental - Vimarsana News

Junshi Biosciences Announces Approval of Supplemental

SHANGHAI, China, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading...

Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection - Vimarsana News

Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection

SHANGHAI, China, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated

WOW! Executives Take Top Spots on Institutional Investor's 2023 All-America Executive Team Rankings for Excellent Leadership - Vimarsana News

WOW! Executives Take Top Spots on Institutional Investor's 2023 All-America Executive Team Rankings for Excellent Leadership

/PRNewswire/ -- WOW! Internet, Cable & Phone (NYSE: WOW), a leading broadband services provider, today announced three of its leaders were recognized by...